Walker Barrier Systems Builds Mobile Clean Rooms for Texas A&M University System Facility
March 11 2014 - 4:15PM
Walker Barrier Systems, a producer of isolation and containment
equipment within Wabash National Corporation's (NYSE:WNC) Walker
Group division, announced today that it has built and delivered the
first of eight mobile clean rooms for the Texas A&M Center for
Innovation in Advanced Development and Manufacturing (CIADM).
Walker Barrier Systems has more than 20 years of experience
providing isolation equipment to more than 100 companies in the
pharmaceutical and biotechnology industries.
"The ability to leverage Walker Barrier Systems' position as the
leading brand of containment and isolation technologies will
provide the highest quality, best value products and enhance the
Texas A&M CIADM initiatives to establish flexible manufacturing
capabilities," said Dr. Gerald Parker, CIADM principal
investigator.
The Texas A&M Center for Innovation is home to the National
Center for Therapeutics Manufacturing (NCTM), which provides a
flexible facility architecture for the development and production
of vaccines and therapeutics for use in clinical trials. This
adaptability is achieved using mobile clean rooms, which are small,
self-contained laboratories configured for individual manufacturing
processes. This technology represents a major breakthrough for the
manufacture of drugs and therapeutics, as mobile clean rooms
provide completely isolated and contained environments that enable
multiple therapeutics to be manufactured simultaneously in a single
facility. The addition of eight new mobile clean rooms to the NCTM
will greatly enhance the facility and the development and
manufacturing capacity of the CIADM.
The Walker Barrier Systems mobile clean room design will allow
the NCTM to manufacture clinical grade materials at enhanced levels
of compliance. Walker Barrier Systems units, constructed with
Wabash National's DuraPlate® composite panel technology, are built
to support a broad array of processes and platforms that will be
required by CIADM to manufacture biosecurity medical
countermeasures.
"While mobile, these clean rooms are approximately 48 feet long
and 18 feet wide, providing full-scale manufacturing capabilities,"
said Dave Nick, vice president and general manager of Walker Group
Engineered Products. "In addition, they are designed to be joined
together to create larger suites to fit specific application
requirements. The mobile clean rooms bring together Walker Barriers
Systems' leading solutions in isolation and containment into a
rapidly deployable and flexible manufacturing facility."
Construction of the mobile clean rooms began in May 2013, and
all eight are expected to be in operation at the NCTM by early
2014. The first unit was delivered in January 2014.
Learn more about Walker Barrier Systems' mobile clean rooms at
the International Pharmaceutical Expo (INTERPHEX) March 18–20,
2014, in New York City.
About Wabash National Corporation
Headquartered in Lafayette, Ind., Wabash National Corporation
(NYSE:WNC) is a diversified industrial manufacturer and North
America's leading producer of semi-trailers and liquid
transportation systems. Established in 1985, the company
specializes in the design and production of dry freight vans,
refrigerated vans, platform trailers, liquid tank trailers,
intermodal equipment, engineered products and composite products.
Its innovative products are sold under the following brand names:
Wabash National®, Transcraft®, Benson®, DuraPlate®, Walker
Transport, Walker Defense Group, Walker Barrier Systems, Walker
Engineered Products, Brenner® Tank, Beall®, Garsite, Progress Tank,
TST®, Bulk Tank International and Extract Technology®. To learn
more, visit www.wabashnational.com.
About the Texas A&M Center for
Innovation
The Texas A&M Center for Innovation in Advance Development
and Manufacturing (CIADM) is one of three centers established in
June, 2012 by the US Department of Health and Human Services to
enhance the nation's emergency preparedness against emerging
infectious diseases, including pandemic influenza, and chemical,
biological, radiological and nuclear threats. The Center is founded
on an initial $285.6 million investment, including a $176.6 million
contribution from the US Department of Health and Human Services,
with the remainder cost-shared by commercial and academic proposal
partners. The Center will perform research and advanced development
to accelerate vaccines and other medical products through
pre-clinical and clinical development and produce these products in
cases of pandemics or other national emergencies. Through these
activities, the Center will address a recognized shortcoming in
preparedness and response to known and unknown threats, and will
improve our nation's ability to protect the health of its citizens
in emergency situations.
CONTACT: Media Contact:
Dana Stelsel
(765) 771-5766
dana.stelsel@wabashnational.com
Media Contact:
Patricia Haigwood
(979) 436-9106
haigwood@tamhsc.edu
Wabash National (NYSE:WNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wabash National (NYSE:WNC)
Historical Stock Chart
From Apr 2023 to Apr 2024